Hepatitis Testing Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™
Hepatitis Testing Market worth $3.6 billion by 2026 – Exclusive Report by MarketsandMarkets™
Stay updated with breaking news from Vela Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hepatitis Testing Market worth $3.6 billion by 2026 – Exclusive Report by MarketsandMarkets™
/PRNewswire/ -- Vela Diagnostics announced that its Sentosa® SQ HIV-1 Genotyping Assay is covered for reimbursement from The Centers for Medicare and Medicaid...
/PRNewswire/ -- According to the new market research report "Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis),...
Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy USA - English Share this article Share this article SINGAPORE, June 3, 2021 /PRNewswire/ -- Vela Diagnostics announced a collaboration with the National Cancer Centre of Singapore (NCCS) to develop a molecular diagnostic assay to predict individual patients' responses to a cancer therapy called Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors (TKIs). Being able to predict an individual's response will help clinicians determine if EGFR-TKIs are a suitable the...
Molecular Diagnostics Market worth $31.8 billion by 2026 - Exclusive Report by MarketsandMarkets "Molecular Diagnostics Market by Product & Service(Reagents, Kits, PoC & Tabletop Instruments), Application(COVID-19, Hepatitis, HAI, HIV, Oncology, Genetic Tests), Technology (PCR, NGS, ISH), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2026", published by MarketsandMarkets, the global market is projected to reach USD 31.8 billion by 2026 from USD 17.8 billion in 2021, at a 12.3% CAGR. Browse in-depth TOC on Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.a...